Koyfin Home > Directory > Health Care > Arena Pharmaceuticals > Long-Term Investments

Arena Pharmaceuticals Long-Term Investments Chart (ARNA)

Arena Pharmaceuticals annual/quarterly Long-Term Investments from 2001 to 2018.
  • Arena Pharmaceuticals Long-Term Investments for the quarter ending December 12, 2018 was $367m a 69.22% increase of 254m year over year
  • Arena Pharmaceuticals Long-Term Investments for the last 12 months ending December 12, 2018 was $367m a 69.22% increase of 254m year over year
  • Arena Pharmaceuticals Annual Long-Term Investments for 2018 was $367m a 93.39% increase of 343m from 2017
  • Arena Pharmaceuticals Annual Long-Term Investments for 2017 was $24m
Other Cash Flow Metrics:
  • Arena Pharmaceuticals Cash Flow from Operations for the quarter ending September 09, 2018 was $-31m a 40.98% decrease of -13m year over year
  • Arena Pharmaceuticals Levered Free Cash Flow (FCF) for the quarter ending September 09, 2018 was $-18m a 99.28% decrease of -18m year over year
  • Arena Pharmaceuticals Total Revenue for the quarter ending September 09, 2018 was $4m a -330.00% decrease of -12m year over year
View Chart On Koyfin

Quarterly ARNA Long-Term Investments Data

12/2018$367m
09/2018$53m
06/2018$91m
03/2018$113m
12/2017$24m
09/2001$5m

Annual ARNA Long-Term Investments Data

2018$367m
2017$24m